Clinical Study of a Proprietary Formulation of a Nutritional Supplement in Overweight Subjects
Obesity is a growing worldwide epidemic and is an independent risk factor for the development of metabolic syndrome, type 2 diabetes, and cardiovascular disease which are leading causes of morbidity and mortality. GlycaCare™ Plus is a proprietary dietary supplement (Sabinsa Corporation, NJ) comprising of extracts of natural products and trace minerals, with suggestive pre-clinical and clinical evidence for improving diabetic symptoms. The objective of this study was to evaluate the effect of GlycaCare™ Plus to improve insulin sensitivity and glucose tolerance in a pilot, randomized, double-blind, ...
(For more, see "View full record.")